PROPRANOLOL IN THREATENED MYOCARDIAL-INFARCTION

被引：0
|
作者：
FOX, KAA
OLIVER, MF
机构：
来源：
LANCET | 1979年 / 1卷 / 8115期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：555 / 555
页数：1
相关论文
共 50 条
  • [21] HEMORHEOLOGICAL PERTURBATIONS IN THREATENED MYOCARDIAL-INFARCTION SYNDROME
    ZANNAD, F
    LAPREVOTEHEULLY, MC
    STOLTZ, JF
    ALIOT, E
    MORIN, D
    LARCAN, A
    GILGENKRANTZ, JM
    [J]. ANNALES DE CARDIOLOGIE ET D ANGEIOLOGIE, 1983, 32 (06): : 426 - 426
  • [22] PROPRANOLOL MAY PREVENT DEVELOPMENT OF MYOCARDIAL-INFARCTION
    GARABEDIAN, HD
    EISENHAUER, AC
    LEINBACH, RC
    GOLD, HK
    [J]. CLINICAL RESEARCH, 1984, 32 (02): : A167 - A167
  • [23] PROPRANOLOL-INDUCED HYPOGLYCEMIA AND MYOCARDIAL-INFARCTION
    WRAY, R
    SUTCLIFFE, SB
    [J]. BMJ-BRITISH MEDICAL JOURNAL, 1972, 2 (5813): : 592 - +
  • [24] INCREASED PLASMA PROPRANOLOL BINDING IN MYOCARDIAL-INFARCTION
    ROUTLEDGE, PA
    STARGEL, WW
    WAGNER, GS
    SHAND, DG
    [J]. BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 1980, 9 (04) : 438 - 440
  • [25] MYOCARDIAL-INFARCTION IN THE DOG - EFFECTS OF INTRAVENOUS PROPRANOLOL
    FOX, K
    WELMAN, E
    SELWYN, A
    [J]. AMERICAN JOURNAL OF CARDIOLOGY, 1980, 45 (04): : 769 - 774
  • [26] PROPRANOLOL AND EXPERIMENTAL MYOCARDIAL-INFARCTION - SUBSTRATE EFFECTS
    OPIE, LH
    THOMAS, M
    [J]. POSTGRADUATE MEDICAL JOURNAL, 1976, 52 : 124 - 134
  • [27] ROLE OF PROPRANOLOL IN TREATMENT OF ACUTE MYOCARDIAL-INFARCTION
    MUELLER, HS
    AYRES, SM
    [J]. PROGRESS IN CARDIOVASCULAR DISEASES, 1977, 19 (05) : 405 - 412
  • [28] HEMODYNAMIC EFFECTS OF PROPRANOLOL IN ACUTE MYOCARDIAL-INFARCTION
    AMSTERDA.EA
    HILLIARD, G
    WILLIAMS, DO
    CAUDILL, C
    VISMARA, L
    MASSUMI, RA
    MASON, DT
    [J]. CIRCULATION, 1973, 48 (04) : 138 - 138
  • [29] PROPRANOLOL IN ACUTE MYOCARDIAL-INFARCTION AND IN THE POSTINFARCTION YEARS
    POPOV, VG
    MARTYNOV, IV
    ALUSHKOV, MV
    VORONIN, VA
    [J]. TERAPEVTICHESKII ARKHIV, 1986, 58 (06): : 53 - 58
  • [30] PROPRANOLOL DISPOSITION AFTER ACUTE MYOCARDIAL-INFARCTION
    PAXTON, JW
    NORRIS, RM
    [J]. CLINICAL PHARMACOLOGY & THERAPEUTICS, 1984, 36 (03) : 337 - 342
12345